Genetic Medicines for Health and Longevity
Oisín has a robust pipeline targeting multiple drivers of age-related conditions.
We have programs that target frailty by stimulating muscle growth, selectively kill fat cells, and remove senescent cells.
Our therapies leverage a new, non-viral delivery technology known as Fusogenix™ Proteo-Lipid Vehicle (PLV). This technology enables extensive extrahepatic biodistribution for both DNA and RNA payloads and permits safe repeated dosing.